Tahata, Yuki
Hikita, Hayato
Mochida, Satoshi
Enomoto, Nobuyuki
Kawada, Norifumi
Kurosaki, Masayuki
Ido, Akio
Miki, Daiki
Yoshiji, Hitoshi
Takikawa, Yasuhiro
Sakamori, Ryotaro
Hiasa, Yoichi
Nakao, Kazuhiko
Kato, Naoya
Ueno, Yoshiyuki
Yatsuhashi, Hiroshi
Itoh, Yoshito
Tateishi, Ryosuke
Suda, Goki
Takami, Taro
Nakamoto, Yasunari
Asahina, Yasuhiro
Matsuura, Kentaro
Yamashita, Taro
Kanto, Tatsuya
Akuta, Norio
Terai, Shuji
Shimizu, Masahito
Sobue, Satoshi
Miyaki, Tomokatsu
Moriuchi, Akihiro
Yamada, Ryoko
Kodama, Takahiro
Tatsumi, Tomohide
Yamada, Tomomi
Takehara, Tetsuo http://orcid.org/0000-0001-5036-3457
Clinical trials referenced in this document:
Documents that mention this clinical trial
Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis
https://doi.org/10.1007/s00535-021-01845-5
Funding for this research was provided by:
Gilead Sciences
Ministry of Health Labor and Welfare of Japan
Japan Agency for Medical Research and Development (JP20fk0210058)
Article History
Received: 13 September 2021
Accepted: 20 December 2021
First Online: 20 January 2022
Declarations
:
: Satoshi Mochida received research grants from Janssen Pharmaceutical K. K., EA Pharma Co, Ltd., MIC Medical Corp., AbbVie GK, EPS International Holdings Co., Ltd. and Gilead Sciences, Inc. and scholarship grants from Toray Industries Inc, AbbVie GK, ASKA Pharmaceutical Co., Ltd, Eisai Co., Ltd, Sumitomo Dainippon Pharma Co., Ltd and EA Pharma Co., Ltd. and is on the speakers’ bureau for MSD K. K, Gilead Sciences, Inc, Toray Industries Inc, AbbVie GK, Sumitomo Dainippon Pharma Co., Ltd, Eisai Co., Ltd, Otsuka Pharmaceutical Co., Ltd and ASKA Pharmaceutical., Ltd. Norifumi Kawada received research grants from Takeda Pharmaceutical Company Limited, Chugai Pharmaceutical Co., Ltd, AstraZeneca plc, MSD co., Ltd, Gilead Sciences, Inc, GlaxoSmithKline plc and Bristol Myers Squibb. and scholarship grants from AbbVie GK, Otsuka Pharmaceutical Co., Ltd and Eisai Co., Ltd. and is on the speakers’ bureau for AbbVie GK, MSD Co., Ltd and Gilead Sciences, Inc. Masayuki Kurosaki is on the speakers’ bureau for Gilead Sciences, Inc and AbbVie GK. Hitoshi Yoshiji received research grants from AbbVie GK, Otsuka Pharmaceutical Co., Ltd and Asuka Pharmaceutical Co., Ltd. and is on the speakers’ bureau for Gilead Sciences, Inc, Otsuka Pharmaceutical Co., Ltd, Sumitomo Dainippon Pharma Co., Ltd, Asuka Pharmaceutical Co., Ltd and AbbVie GK. Naoya Kato received scholarship grants from Gilead Sciences, Inc. and is on the speakers’ bureau for Gilead Sciences, Inc. Yoshiyuki Ueno received scholarship grants from AbbVie GK, EA Pharma and Otsuka Pharmatheutical and is on the speakers’ bureau for EA Pharma, AbbVie GK. and Otsuka Pharmaceutical. Hiroshi Yatsuhashi received research grants from AbbVie GK. Yoshito Itoh received research grants from MSD, Gilead Sciences Inc and Bristol-Myers Squibb Company and scholarship grants from Bristol-Myers Squibb Company, AbbVie GK and MSD and is on the speakers’ bureau for AbbVie GK, Gilead Sciences, Inc. and MSD. Goki Suda received research grants from Gilead Sciences, Inc. Taro Takami belongs to a donation-funded department funded by SHIBUYA Corporation. Yasuhiro Asahina belongs to a donation-funded department funded by Gilead Sciences, Inc., AbbVie GK, Toray Industries Inc and Fujirebio Inc. Tatsuya Kanto is on the speakers’ bureau for Gilead Sciences, Inc.and AbbVie GK. Norio Akuta is on the speakers’ bureau for AbbVie GK, Gilead Sciences, Inc. and Mitsubishi Tanabe Pharma Corporation. Shuji Terai received research grants from Intersterm Routo, Asuka, Tsumura, Abbot, Toso, Sysmex, Kowa, Stemrim, Towa, Gilead, Chiome, Shionogi, Niohonseiyaku, Kyowa and BioMimetics Sympathies and scholarship grants from AbbVie, Dainipponsumitomo, Aasakikasei, Niohokkayaku, Eisai, EA pharma, Boston and Takeda and is on the speakers’ bureau for Otsuka, Gilead, Takeda, Asuka, MSD and DaiichiSankyo. Tetsuo Takehara received research grants from Gilead Sciences, Inc., MSD, AbbVie GK. and Chugai Pharmaceutical Co., Ltd. and is on the speakers’ bureau for Gilead Sciences, Inc., AbbVie GK and MSD. All other authors declare that they have no conflicts of interest to disclose.